Clinical Trials Browser

Unknown × Hyperthermia × Immune Checkpoint Inhibitors × Clear all

NCT05520853 2022-08-30

SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLC

Phase 2 Unknown

Hyperthermia, Carcinoma, Non-Small-Cell Lung